Settlement Up to $10M Gains Final Nod In Celexa/Lexapro Marketing Suit

A potential $10.35 million federal class settlement in a Missouri Celexa/Lexapro deceptive marketing case won final approval from the District of Massachusetts over an objection from a plaintiff in a similar Missouri state court proceeding (In re Celexa &Lexapro Sales Prac. & Mktg. Litig., D. Mass., 09-2067, 9/8/14).

The settlement, as approved Sept. 8, provides for attorneys’ fees of up to $2,796,250, and incentive payments of $10,000 each to the named plaintiffs Ruth Dunham and Tanya Shippy.

Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts denied objector Natalie Luster’s request for ...